Search
Now showing items 1-4 of 4
The impact of PheroidTM technology on the bioavailability and efficacy of anti-tuberculosis drugs in an animal model
(North-West University, 2009)
Tuberculosis (TB) is a worldwide pandemic with vast challenges in the fight against the
disease. Challenges include the long and tedious treatment regimens and chemotherapy with
adverse side effects. One approach in ...
Formulation, in vitro release and transdermal diffusion of salicylic acid and topical niacinamide
(North-West University, 2009)
Acne affects as many as 80% of young adults and adolescents all over the world. This detrimental condition can be classified into four stages: (a) open comedo (blackhead), (b) closed comedo (whitehead), (c) papule and (d) ...
Formulation, in-vitro release and transdermal diffusion of alpha-lipoic acid
(North-West University, 2009)
Acne is a common disease characterised by follicular hyperkeratinisation, bacterial hipercolonisation as well as immune reactions and inflammation. In acne, reactive oxygen species (ROS) may be released from the damaged ...
Peroral and nasal delivery of insulin with PheroidTM technology
(North-West University, 2009)
Since its initial discovery in 1922 by Banting and Best, the formulation of an oral insulin delivery system has ever been so troublesome. Unfortunately, insulin is indispensable in the treatment of diabetes mellitus, which ...